Navigation Links
TheraSeed® Pd-103 Seed, Calibrated

ProductsTheraSeed® Pd-103 Seed, Calibrated
Company C. R. Bard, Inc.
Item TheraSeed® Pd-103 Seed, Calibrated
Features 
  • Concave ends may lower the rate of seed migration.
  • Excellent CT and Fluoroscopic visibility.
  • Over 10 years clinical data support.
  • Studies demonstrate clinical efficacy throughout the Gleason Score Range.
  • Worlds largest cyclotron-based Pd-103 supplier.
  • Wide range of activities available.
  • 100% assay to ensure accurate activity level.
Description The TheraSeed® Pd-103 implant is a combination of innovative design, consistently reliable dosimetry and remarkable visibility that makes TheraSeed® treatment an ideal choice for your brachytherapy patients. You can be confident that every TheraSeed® implant order is backed by our seed management services which is required by clinicians who must meet the time-critical demands of brachytherapy.
Info C. R. Bard, Inc.
Customer Service: (800) 367-2273
Web site: http://www.crbard.com

Related medicine products :

1. TheraSeed® Pd-103 Seed, Loose
2. TheraSeed® Pd-103 Seed, Preloaded in Needle
3. Prospera® Pd-103 Seeds
4. BrachySource® I-125 Seed, Preloaded in Needle
5. BrachySource® I-125 Seed, Loose
6. BrachySource® I-125 Seed, Calibrated
7. 5.0mm Calibrated Trephine Handle
8. 5.5mm Calibrated Trephine Handle
9. 6.25mm Calibrated Trephine Handle
10. 6.0mm Calibrated Trephine Handle
11. 6.75mm Calibrated Trephine Handle
... primers and a FAM-labeled probe that is designed ... Staphylococcus protein A gene. In addition, this ASR ... for an internal control sequence. This ASR requires ... Red reporter dyes such as the Cepheid SmartCycler ...
Clot-based Assay for Anti-FXa and/or Anti-Iia Therapies...
Reptilase-Time from Bothrops atrox...
Controls for APC Resistance / Factor V Leiden Functional Assay...
Medicine Products:
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 One of Australia,s successful ... of a new biotechnology company, Noxopharm Limited [ABN 50 608 966 ... and to list on the ASX. Noxopharm is a ... enter a Phase 1 clinical study later this year. ... of the biggest problems facing cancer patients - the ability of ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... 27, 2016  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ... whatever measures required to build a strong and stable ... currently listed on the OTC Markets-pink current trading platform. ... CEO, "We are seeing an anomaly in market trading ... only by the Company, but shareholders and market players ...
Breaking Medicine Technology: